Astrana Health (NASDAQ:ASTH) Announces Quarterly Earnings Results

Astrana Health (NASDAQ:ASTH) announced its earnings results on Thursday. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37), Zacks reports. The business had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. Astrana Health updated its FY 2025 guidance to EPS.

Astrana Health Stock Down 26.8 %

Shares of NASDAQ ASTH opened at $25.38 on Friday. Astrana Health has a 1 year low of $23.12 and a 1 year high of $63.20. The firm’s 50 day moving average price is $35.01 and its 200 day moving average price is $44.65. The firm has a market cap of $1.43 billion, a P/E ratio of 19.52, a price-to-earnings-growth ratio of 1.37 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Analysts Set New Price Targets

Several research analysts recently issued reports on ASTH shares. Stifel Nicolaus cut their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Robert W. Baird increased their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Truist Financial dropped their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Astrana Health has an average rating of “Moderate Buy” and an average price target of $65.60.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.